New Leader Poised to Continue Delivering Strong
Performance
The Chemours Company ("Chemours") (NYSE: CC), a global chemistry
company with leading market positions in Titanium Technologies,
Thermal & Specialized Solutions, and Advanced Performance
Materials, today announced the appointment of Joseph Martinko as
President, Thermal & Specialized Solutions (TSS), effective
immediately. Martinko was appointed interim leader on June 1 and
stood out as the top candidate following an internal and external
search.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230726287313/en/
Joseph Martinko President, Thermal &
Specialized Solutions Chemours (Photo: Business Wire)
"Joe has been a principal architect of the entire Opteon™
solutions portfolio and brings unmatched knowledge of our thermal
management products, market, and customers to this role. In
addition, having led the commercialization and market transition to
low-GWP Opteon™ products for the mobile and stationary
refrigeration and foam expansion markets, he knows what it takes to
innovate in the space as we look for more sustainable solutions,"
said Mark Newman, Chemours President and Chief Executive Officer.
"With Joe's deep commercial and regulatory experience and his
proven track record, I have no doubt that the TSS team will
continue to deliver strong financial performance and business
growth under his leadership."
Martinko brings to the role over 30 years of expertise in the
chemical industry, with more than 20 years of experience across TSS
and Chemours’ legacy fluoroproducts business in a range of global
market, product, and regional leadership roles. Before he was
appointed to lead TSS, he served as the Sr. Business Director,
Americas, a role in which he drove business strategy, delivered
record-breaking financial performance, and built a high-performing
team. Prior to that, Martinko has held various roles in the
fluoroproducts business with responsibility for regulatory and
advocacy, customer service, marketing, sales, technical service,
asset strategy and product management. Before Chemours, Martinko
worked for over 20 years with DuPont in various business leadership
and manufacturing roles.
"The TSS business has a solid foundation upon which we will
continue to build," said Joseph Martinko, President of Chemours
Thermal & Specialized Solutions. "We have an industry-leading
product portfolio, an exciting innovation pipeline, and a highly
capable and resolute team that knows how to win. All of this
ensures that we are well positioned for continued growth. I have
every confidence in our TSS team's ability to continue executing
our strategy and delivering strong business results."
About The Chemours Company The Chemours Company (NYSE:
CC) is a global leader in Titanium Technologies, Thermal &
Specialized Solutions, and Advanced Performance Materials providing
its customers with solutions in a wide range of industries with
market-defining products, application expertise and chemistry-based
innovations. We deliver customized solutions with a wide range of
industrial and specialty chemicals products for markets, including
coatings, plastics, refrigeration and air conditioning,
transportation, semiconductor, and consumer electronics, general
industrial, and oil and gas. Our flagship products are sold under
prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™,
Viton™, Nafion™, and Krytox™. The company has approximately 6,600
employees and 29 manufacturing sites serving approximately 2,900
customers in approximately 120 countries. Chemours is headquartered
in Wilmington, Delaware and is listed on the NYSE under the symbol
CC.
For more information, we invite you to visit chemours.com or
follow us on Twitter @Chemours or LinkedIn.
Forward-Looking Statements This press release contains
forward-looking statements, within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, which involve risks and uncertainties.
Forward-looking statements provide current expectations of future
events based on certain assumptions and include any statement that
does not directly relate to a historical or current fact. The words
"believe," "expect," "will," "anticipate," "plan," "estimate,"
"target," "project" and similar expressions, among others,
generally identify "forward-looking statements," which speak only
as of the date such statements were made. These forward-looking
statements may address, among other things, the outcome or
resolution of any pending or future environmental liabilities, the
commencement, outcome or resolution of any regulatory inquiry,
investigation or proceeding, the initiation, outcome or settlement
of any litigation, changes in environmental regulations in the U.S.
or other jurisdictions that affect demand for or adoption of our
products, anticipated future operating and financial performance
for our segments individually and our company as a whole, business
plans, prospects, targets, goals and commitments, capital
investments and projects and target capital expenditures, plans for
dividends or share repurchases, sufficiency or longevity of
intellectual property protection, cost reductions or savings
targets, plans to increase profitability and growth, our ability to
make acquisitions, integrate acquired businesses or assets into our
operations, and achieve anticipated synergies or cost savings, all
of which are subject to substantial risks and uncertainties that
could cause actual results to differ materially from those
expressed or implied by such statements. Forward-looking statements
are based on certain assumptions and expectations of future events
that may not be accurate or realized, such as full year guidance
relying on models based upon management assumptions regarding
future events that are inherently uncertain. These statements are
not guarantees of future performance. Forward-looking statements
also involve risks and uncertainties that are beyond Chemours'
control. Matters outside our control, including general economic
conditions and the COVID-19 pandemic, have affected or may affect
our business and operations and may or may continue to hinder our
ability to provide goods and services to customers, cause
disruptions in our supply chains such as through strikes, labor
disruptions or other events, adversely affect our business
partners, significantly reduce the demand for our products,
adversely affect the health and welfare of our personnel or cause
other unpredictable events. Additionally, there may be other risks
and uncertainties that Chemours is unable to identify at this time
or that Chemours does not currently expect to have a material
impact on its business. Factors that could cause or contribute to
these differences include the risks, uncertainties and other
factors discussed in our filings with the U.S. Securities and
Exchange Commission, including in our Quarterly Report on Form 10-Q
for the quarter ended March 31, 2023, and in our Annual Report on
Form 10-K for the year ended December 31, 2022. Chemours assumes no
obligation to revise or update any forward-looking statement for
any reason, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230726287313/en/
INVESTORS Brandon Ontjes VP, Financial Planning &
Analysis, and Investor Relations +1.302.773.3300
investor@chemours.com
Kurt Bonner, Manager, Investor Relations +1.302.773.0026
investor@chemours.com
NEWS MEDIA Thom Sueta Director of Corporate
Communications +1.302.773.3903 media@chemours.com
Chemours (NYSE:CC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Chemours (NYSE:CC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024